BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HucMSC intramyocardial therapy readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HucMSC intramyocardial therapy\, from Cli
 nicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07265349-613@assetmemo.bio
DTSTAMP:20261121T005935Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:HucMSC intramyocardial therapy: Phase 1/2 readout est. (NCT07265349
 )
DESCRIPTION:HucMSC intramyocardial therapy\, phase 1/2\, Heart Failure.\nSt
 udy: A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs f
 or the Treatment of Chronic Heart Failure\nEstimated primary completion: 3
 1 December 2026. This is a ClinicalTrials.gov estimate\, not a confirmed r
 eadout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/hucm
 sc-intramyocardial-therapy#upcoming-events\nRegistry record: https://clini
 caltrials.gov/study/NCT07265349
URL:https://assetmemo.bio/drug/hucmsc-intramyocardial-therapy#upcoming-even
 ts
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
